En esta página
01ALGS precio
02Instantánea
03Gráfico
04Divisiones de acciones
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
26Mis Métricas
ALGS Aligos Therapeutics, Inc. - Common stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 6, 2026
$5,54
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$3,98mínimo 52 semanas
$13,69máximo 52 semanas
Capitalización Bursátil (MRQ)
$35M
P/E (TTM)
-4.8
BPA (TTM)
$-1.16
Ingresos (TTM)
$4M
tus insignias
Rango 52S
$4–$14
Calificación del Analista
BUY
Precio Objetivo
$52
P/E
-4.8
ROE
-113.6%
Margen de Beneficio Neto
-2031.1%
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
ALGS Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$5.54
Capitalización Bursátil (MRQ)
$35M
P/E (TTM)
-4.8
BPA (TTM)
$-1.16
Ingresos (TTM)
$4M
ROE (TTM)
-113.6%
Rango 52S
$4–$14
ALGS Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 19 de agosto de 2024 | 1-for-25 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
Ingresos$2M2020-12-31 → 2025-12-31
BPA$-2.452022-12-31 → 2025-12-31
Flujo de caja libre·2020-12-31 → 2024-12-31
Margen neto-2031.1%2023-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | ALGS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E (TTM) | -4.8promedio 5A ≈-4.2 | ≈-4.2 | · | · | |
| P/S (TTM) | 9.2promedio 5A ≈90.1 | ≈90.1 | · | · | |
| P/C (MRQ) | 1.1promedio 5A ≈17.5 | ≈17.5 | · | · | |
| Price / Cash Flow (Precio / Flujo de Caja) | -0.4promedio 5A ≈-28.2 | ≈-28.2 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 0.6promedio 5A ≈23.3 | ≈23.3 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | ALGS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Margen Operativo (TTM) | -2112.1%promedio 5A ≈-2639.1% | ≈-2639.1% | -639.7% | Débil | |
| EBITDA Margin (Margen EBITDA) | -4024.9%promedio 5A ≈-2639.1% | ≈-2639.1% | -639.7% | Débil | |
| Margen antes de impuestos (TTM) | -1945.1%promedio 5A ≈-2040.1% | ≈-2040.1% | · | · | |
| Margen de Beneficio Neto (TTM) | -2031.1%promedio 5A ≈-2052.2% | ≈-2052.2% | -235.8% | Débil | |
| ROA (TTM) | -75.6%promedio 5A ≈-61.8% | ≈-61.8% | -16.9% | Por debajo del promedio | |
| ROE (TTM) | -113.6%promedio 5A ≈-308.4% | ≈-308.4% | -14.0% | Por debajo del promedio | |
| ROIC | -166.5%promedio 5A ≈-23.6% | ≈-23.6% | -60.4% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | ALGS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 2.2promedio 5A ≈4.4 | ≈4.4 | 1.9 | Liquidez sólida | |
| Ratio Rápido (MRQ) | 2.1promedio 5A ≈4.1 | ≈4.1 | 0.9 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | ALGS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | -39.5% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
| Métrica | Tendencia a 5 años | ALGS | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Asset Turnover (Rotación de Activos) | 0.0promedio 5A ≈0.0 | ≈0.0 | 0.0 | En línea | |
| Revenue / Employee (Ingresos / Empleado) | ≈$26.7K | · | · | · |
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
15.7%
Próximo informe
Nov 04, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 4, 2026 | $-0.14 | $-1.09 | 87.2% |
| 31 de marzo de 2026 | $-2.21 | $-2.27 | 2.5% | |
| 31 de diciembre de 2025 | $-1.91 | $-1.89 | -1.1% | |
| 30 de septiembre de 2025 | $-3.04 | $-1.94 | -56.9% | |
| 30 de junio de 2025 | $-1.53 | $-2.41 | 36.5% | |
| 31 de marzo de 2025 | $-2.11 | $-2.85 | 26.0% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $2M | $4M | $6M | $0 | $0 | $0 | |
| R&D Expense | $69M | $70M | $73M | $85M | $104M | $80M | |
| SG&A Expense | $21M | $23M | $31M | $26M | $29M | $18M | |
| Operating Expenses | $90M | $93M | $104M | $111M | $133M | $98M | |
| Operating Income | $-88M | $-89M | $-88M | $-98M | $-128M | $-98M | |
| Pretax Income | $-24M | $-131M | $-87M | $-96M | $-128M | $-108M | |
| Income Tax | $314.0K | $331.0K | $795.0K | $106.0K | $143.0K | $161.0K | |
| Net Income | $-24M | $-131M | $-88M | $-96M | $-128M | $-109M | |
| EPS (Basic) | $-2.45 | $-20.94 | $-34.20 | $-2.25 | · | · | |
| EPS (Diluted) | $-2.45 | $-20.94 | $-34.20 | $-2.25 | · | · | |
| Shares (Basic) | 9,884,955 | 6,264,612 | 2,563,470 | 42,695,227 | · | · | |
| Shares (Diluted) | 9,884,955 | 6,264,612 | 2,563,470 | 42,695,227 | · | · | |
| EBITDA | $-88M | $-89M | $-88M | $-98M | $-128M | $-98M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $18M | $37M | $136M | $81M | $187M | $220M | |
| Short-term Investments | $60M | $20M | · | $44M | $4M | $23M | |
| Other Current Assets | $5M | $5M | $5M | $8M | $14M | $6M | |
| Current Assets | $83M | $62M | $141M | $134M | $204M | $250M | |
| PP&E (Net) | $2M | $2M | $3M | $5M | $6M | $8M | |
| PP&E (Gross) | $15M | $14M | $14M | $14M | $13M | $12M | |
| Accum. Depreciation | $13M | $12M | $11M | $10M | $7M | $4M | |
| Other Non-current Assets | $715.0K | $627.0K | $625.0K | $634.0K | $866.0K | $377.0K | |
| Total Assets | $89M | $70M | $152M | $147M | $235M | $265M | |
| Accounts Payable | $4M | $3M | $3M | $5M | $3M | $3M | |
| Accrued Liabilities | $14M | $16M | $17M | $16M | $25M | $17M | |
| Current Liabilities | $21M | $22M | $24M | $33M | $39M | $30M | |
| Capital Leases | $2M | $5M | $8M | $9M | $11M | $10M | |
| Other Non-current Liabilities | · | · | · | · | $133.0K | $379.0K | |
| Total Liabilities | $35M | $99M | $59M | $43M | $51M | $45M | |
| Common Stock | $9.0K | $8.0K | $7.0K | $4.0K | $4.0K | $4.0K | |
| Retained Earnings | $-642M | $-618M | $-487M | $-399M | $-303M | $-175M | |
| AOCI | $468.0K | $451.0K | $545.0K | $401.0K | $452.0K | $-188.0K | |
| Stockholders' Equity | $54M | $-29M | $92M | $104M | $185M | $220M | |
| Liabilities + Equity | $89M | $70M | $152M | $147M | $235M | $265M | |
| Shares Outstanding | 6,178,230 | 3,864,436 | 3,003,855 | 42,922,980 | 42,690,229 | 38,120,606 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $8M | $13M | $15M | $13M | $3M | |
| Deferred Tax | · | $0 | $0 | $0 | $0 | $0 | |
| Operating Cash Flow | $-83M | $-81M | $-79M | $-79M | $-116M | $-74M | |
| CapEx | · | $130.0K | $19.0K | $943.0K | $892.0K | $2M | |
| Investing Cash Flow | $-38M | $-18M | $45M | $-26M | $3M | $33M | |
| Stock Issued | · | · | $23.0K | · | · | · | |
| Financing Cash Flow | $102M | $355.0K | $88M | $164.0K | $79M | $192M | |
| Taxes Paid | $315.0K | · | · | · | · | · | |
| Free Cash Flow | · | $-81M | $-79M | $-80M | $-117M | $-76M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Margin | -4024.9% | -2469.0% | -1423.5% | · | · | · | |
| Net Margin | -1106.7% | -3633.7% | -1416.2% | · | · | · | |
| Pretax Margin | -1092.4% | -3624.5% | -1403.4% | · | · | · | |
| EBITDA Margin | -4024.9% | -2469.0% | -1423.5% | · | · | · | |
| ROA | -30.5% | -118.4% | -58.8% | -50.3% | -51.3% | -52.7% | |
| ROE | -31.1% | -1242.4% | -119.4% | -85.0% | -63.9% | -260.4% | |
| ROIC | -166.5% | 308.5% | -96.6% | -94.0% | -69.5% | -44.5% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 3.9 | 2.9 | 5.9 | 4.0 | 5.2 | 8.3 | |
| Quick Ratio | 3.7 | 2.6 | 5.7 | 3.8 | 4.9 | 8.0 |
Eficiencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Book Value / Share | $8.67 | $-7.50 | $1.23 | $2.42 | $4.33 | $6.01 | |
| Revenue / Share | $0.22 | $0.58 | $0.10 | · | · | · | |
| Cash Flow / Share | $-8.35 | $-12.89 | $-1.23 | · | · | · | |
| Cash / Share | $2.96 | $9.57 | $1.81 | $1.90 | $4.38 | $6.02 | |
| EPS (TTM) | $-2.45 | $-20.94 | $-34.20 | $-2.25 | · | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -39.5% | -41.7% | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $4M | $6M | $0 | $0 | $0 | |
| Net Income TTM | $-24M | $-131M | $-88M | $-96M | $-128M | $-109M | |
| Market Cap | $58M | $154M | $1.25B | $1.02B | $12.67B | $25.30B | |
| P/E | -3.8 | -1.9 | -0.5 | -10.6 | · | · | |
| P/S | 26.3 | 42.6 | 201.4 | · | · | · | |
| P/B | 1.1 | -5.3 | 13.5 | 9.8 | 68.6 | 115.0 | |
| P / Tangible Book | 1.1 | · | 13.5 | 9.8 | 68.6 | 115.0 | |
| P / Cash Flow | -0.7 | -1.9 | -15.8 | -12.9 | -109.5 | -340.7 | |
| P / FCF | · | -1.9 | -15.8 | -12.7 | -108.7 | -331.5 | |
| Earnings Yield | -26.3% | -52.6% | -206.0% | -9.4% | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $3M | $169.0K | $741.0K | $965.0K | $311.0K | $606.0K | $1M | $1M | $694.0K | $672.0K | $1M | $4M | $140.0K | · | $0 | |
| R&D Expense | $24M | $23M | $17M | $24M | $14M | $15M | $16M | $17M | $21M | $16M | $22M | $16M | $17M | $18M | $19M | $18M | |
| SG&A Expense | $6M | $6M | $5M | $5M | $6M | $5M | $5M | $5M | $6M | $7M | $6M | $6M | $9M | $9M | $7M | $5M | |
| Operating Expenses | $30M | $30M | $22M | $29M | $20M | $20M | $21M | $21M | $27M | $23M | $29M | $22M | $26M | $27M | $26M | $23M | |
| Operating Income | $-2M | $-27M | $-22M | $-28M | $-19M | $-19M | $-21M | $-20M | $-26M | $-22M | $-26M | $-19M | $-19M | $-24M | $-23M | $-19M | |
| Pretax Income | $1M | $-23M | $-20M | $-31M | $-16M | $43M | $-82M | $-19M | $5M | $-35M | $-28M | $-18M | $-18M | $-23M | $-22M | $-19M | |
| Income Tax | $3M | $317.0K | $30.0K | $56.0K | $185.0K | $43.0K | $27.0K | $91.0K | $189.0K | $24.0K | $-30.0K | $29.0K | $757.0K | $39.0K | $49.0K | $-43.0K | |
| Net Income | $-2M | $-23M | $-20M | $-32M | $-16M | $43M | $-82M | $-19M | $5M | $-35M | $-28M | $-18M | $-19M | $-23M | $-22M | $-19M | |
| EPS (Basic) | $-0.14 | $-2.21 | $-3.00 | $-3.04 | $-1.53 | $5.12 | $-13.10 | $-3.07 | $0.81 | $-5.58 | $-22.87 | $-10.37 | $-0.43 | $-0.53 | $-0.50 | $-0.44 | |
| EPS (Diluted) | $-0.14 | $-2.21 | $4.23 | $-3.04 | $-1.53 | $-2.11 | $-13.10 | $-3.07 | $0.81 | $-5.58 | $-22.87 | $-10.37 | $-0.43 | $-0.53 | $-0.50 | $-0.44 | |
| Shares (Basic) | 10,430,808 | 10,402,967 | · | 10,369,535 | 10,351,120 | 8,408,481 | · | 6,272,291 | 6,257,713 | 6,246,113 | · | 1,739,847 | 43,215,478 | 42,910,065 | · | 42,761,928 | |
| Shares (Diluted) | 10,430,808 | 10,402,967 | · | 10,369,535 | 10,351,120 | 8,709,693 | · | 6,272,291 | 6,265,853 | 6,246,113 | · | 1,739,847 | 43,215,478 | 42,910,065 | · | 42,761,928 | |
| EBITDA | · | $-27M | · | $-28M | $-19M | $-19M | · | $-20M | $-26M | $-22M | · | $-19M | $-19M | $-24M | · | $-19M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $30M | $30M | $18M | $42M | $19M | $74M | $37M | $35M | $45M | $24M | $136M | $70M | $91M | $79M | $81M | $86M | |
| Short-term Investments | $0 | $25M | $60M | $57M | $104M | $64M | $20M | $40M | $49M | $89M | · | · | $10.0K | $25M | $44M | $56M | |
| Receivables | $28M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Current Assets | $4M | $5M | $5M | $4M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | $3M | $6M | $8M | $8M | |
| Current Assets | $62M | $60M | $83M | $103M | $128M | $143M | $62M | $80M | $100M | $118M | $141M | $75M | $94M | $109M | $134M | $150M | |
| PP&E (Net) | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $5M | $5M | |
| PP&E (Gross) | $15M | $15M | $15M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | $14M | |
| Accum. Depreciation | $13M | $13M | $13M | $12M | $12M | $12M | $12M | $12M | $11M | $11M | $11M | $11M | $10M | $10M | $10M | $9M | |
| Other Non-current Assets | $759.0K | $759.0K | $715.0K | $713.0K | $640.0K | $632.0K | $627.0K | $635.0K | $631.0K | $625.0K | $625.0K | $623.0K | $624.0K | $632.0K | $634.0K | $653.0K | |
| Total Assets | $66M | $65M | $89M | $110M | $135M | $151M | $70M | $88M | $109M | $128M | $152M | $86M | $106M | $122M | $147M | $164M | |
| Accounts Payable | $6M | $8M | $4M | $5M | $4M | $4M | $3M | $3M | $7M | $3M | $3M | $3M | $3M | $3M | $5M | $3M | |
| Accrued Liabilities | $19M | $12M | $14M | $14M | $12M | $11M | $16M | $14M | $12M | $12M | $17M | $12M | $14M | $15M | $16M | $14M | |
| Current Liabilities | $28M | $23M | $21M | $22M | $20M | $19M | $22M | $21M | $24M | $19M | $24M | $22M | $27M | $28M | $33M | $31M | |
| Capital Leases | $288.0K | $659.0K | $2M | $2M | $3M | $4M | $5M | $6M | $6M | $7M | $8M | $8M | $9M | $9M | $9M | $10M | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $133.0K | |
| Total Liabilities | $34M | $33M | $35M | $38M | $33M | $34M | $99M | $38M | $42M | $68M | $59M | $31M | $36M | $37M | $43M | $42M | |
| Common Stock | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K | $8.0K | $8.0K | $8.0K | $7.0K | $7.0K | $4.0K | $0 | $4.0K | $4.0K | $4.0K | |
| Retained Earnings | $-667M | $-665M | $-642M | $-622M | $-591M | $-575M | $-618M | $-536M | $-517M | $-522M | $-487M | $-459M | $-441M | $-422M | $-399M | $-377M | |
| AOCI | $437.0K | $438.0K | $468.0K | $455.0K | $420.0K | $447.0K | $451.0K | $577.0K | $494.0K | $476.0K | $545.0K | $497.0K | $497.0K | $499.0K | $401.0K | $159.0K | |
| Stockholders' Equity | $32M | $32M | $54M | $72M | $102M | $116M | $-29M | $50M | $67M | $60M | $92M | $55M | $70M | $85M | $104M | $122M | |
| Liabilities + Equity | $66M | $65M | $89M | $110M | $135M | $151M | $70M | $88M | $109M | $128M | $152M | $86M | $106M | $122M | $147M | $164M | |
| Shares Outstanding | 6,236,828 | 6,188,186 | 6,178,230 | 6,153,507 | 6,151,274 | 6,114,801 | 3,864,436 | 3,324,780 | 79,785,898 | 75,668,521 | 3,003,855 | 43,502,582 | 43,502,582 | 42,940,089 | 42,922,980 | 42,815,593 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $1M | $1M | $1M | $1M | $959.0K | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $4M | $3M | $3M | |
| Operating Cash Flow | $-25M | $-23M | $-22M | $-24M | $-16M | $-21M | $-18M | $-20M | $-19M | $-23M | $-23M | $-20M | $-14M | $-22M | $-17M | $-17M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | · | $7.0K | $91.0K | $3.0K | |
| Investing Cash Flow | $25M | $35M | $-2M | $48M | $-39M | $-44M | $20M | $10M | $40M | $-89M | $-7.0K | $-9.0K | $25M | $20M | $12M | $32M | |
| Financing Cash Flow | $220.0K | $-62.0K | $123.0K | $-53.0K | $-177.0K | $102M | $97.0K | $-4.0K | $281.0K | $-19.0K | $88M | $-21.0K | $414.0K | $-1.0K | $121.0K | $-19.0K | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | $-22M | · | · |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -951.5% | · | -3827.4% | -1924.0% | -6187.5% | · | -1610.5% | -2489.5% | -3176.7% | · | -1757.7% | -445.8% | -17084.3% | · | · | |
| Net Margin | · | -814.1% | · | -4256.0% | -1643.8% | 13854.7% | · | -1540.7% | 477.0% | -5023.5% | · | -1662.8% | -437.6% | -16396.4% | · | · | |
| Pretax Margin | · | -802.9% | · | -4248.4% | -1624.7% | 13868.5% | · | -1533.4% | 494.8% | -5020.0% | · | -1660.1% | -420.0% | -16368.6% | · | · | |
| EBITDA Margin | · | -951.5% | · | -3827.4% | -1924.0% | -6187.5% | · | -1610.5% | -2489.5% | -3176.7% | · | -1757.7% | -445.8% | -17084.3% | · | · | |
| ROA | · | -21.4% | · | -31.8% | -13.0% | 30.9% | · | -22.1% | 4.7% | -27.9% | · | -14.4% | -13.0% | -13.8% | · | -8.7% | |
| ROE | · | -31.1% | · | -51.7% | -18.8% | 48.9% | · | -36.7% | 7.4% | -48.2% | · | -20.4% | -18.2% | -19.3% | · | -11.0% | |
| ROIC | · | -85.9% | · | -39.6% | -18.4% | -16.5% | · | -40.4% | -37.9% | -36.9% | · | -34.8% | -28.6% | -28.3% | · | -15.5% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 2.6 | · | 4.7 | 6.3 | 7.6 | · | 3.8 | 4.2 | 6.3 | · | 3.3 | 3.5 | 3.9 | · | 4.9 | |
| Quick Ratio | · | 2.4 | · | 4.5 | 6.1 | 7.3 | · | 3.6 | 4.0 | 6.0 | · | 3.1 | 3.3 | 3.7 | · | 4.7 |
Eficiencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $5.14 | · | $11.67 | $16.56 | $19.04 | · | $15.07 | $0.84 | $0.79 | · | $1.26 | $1.60 | $1.97 | · | $2.85 | |
| Revenue / Share | · | $0.27 | · | $0.07 | $0.09 | $0.04 | · | $0.20 | $0.01 | $0.00 | · | $0.02 | $0.10 | $0.00 | · | · | |
| Cash Flow / Share | · | $-2.22 | · | · | · | $-2.40 | · | · | · | $-0.15 | · | · | · | $-0.52 | · | · | |
| Cash / Share | · | $4.84 | · | $6.82 | $3.03 | $12.06 | · | $10.63 | $0.56 | $0.32 | · | $1.62 | $2.09 | $1.83 | · | $2.02 | |
| EPS (TTM) | $-1.16 | $-2.55 | · | $-19.78 | $-19.81 | $-17.47 | · | $-30.71 | $-38.01 | $-39.25 | · | $-11.83 | $-1.90 | $-1.94 | · | · |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $5M | · | $3M | $3M | $3M | · | $4M | $4M | $7M | · | · | · | · | · | · | |
| Net Income TTM | $-76M | $-90M | · | $-86M | $-74M | $-53M | · | $-77M | $-76M | $-100M | · | $-82M | $-82M | $-83M | · | $-112M | |
| Market Cap | · | $46M | · | $60M | $44M | $50M | · | $29M | $698M | $1.85B | · | $812M | $1.06B | $938M | · | $1.18B | |
| P/E | -5.0 | -2.9 | · | -0.5 | -0.4 | -0.5 | · | -0.3 | -0.2 | -0.6 | · | -1.6 | -12.8 | -11.3 | · | · | |
| P/S | 9.6 | 9.8 | · | 23.0 | 14.2 | 15.6 | · | 7.8 | 198.8 | 274.9 | · | · | · | · | · | · | |
| P/B | 1.1 | 1.4 | · | 0.8 | 0.4 | 0.4 | · | 0.6 | 10.4 | 31.0 | · | 14.8 | 15.2 | 11.1 | · | 9.7 | |
| P / Tangible Book | 1.1 | 1.4 | · | 0.8 | 0.4 | 0.4 | · | 0.6 | 10.4 | 31.0 | · | 14.8 | 15.2 | 11.1 | · | 9.7 | |
| P / Cash Flow | · | -2.0 | · | · | · | -2.4 | · | · | · | -81.5 | · | · | · | -41.9 | · | · | |
| Earnings Yield | -20.1% | -34.3% | · | -201.8% | -274.8% | -211.8% | · | -354.6% | -434.4% | -160.2% | · | -63.3% | -7.8% | -8.9% | · | · |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ingresos | $2M | $4M | $6M | $0 | $0 |
| Margen Operativo % | -4024.9% | -2469.0% | -1423.5% | · | · |
| Beneficio neto | $-24M | $-131M | $-88M | $-96M | $-128M |
| EPS Diluido | $-2.45 | $-20.94 | $-34.20 | $-2.25 | · |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 3.9 | 2.9 | 5.9 | 4.0 | 5.2 |
| Ratio Rápido | 3.7 | 2.6 | 5.7 | 3.8 | 4.9 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | · | $-81M | $-79M | $-80M | $-117M |
Propietarios institucionales (13F) 34 declarantes · $15.3M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
34
Valor en tenencia
$15.3M
Nuevas posiciones
5
Posiciones cerradas
9
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 5 (-2 vs trimestre anterior) | 9 (+2 vs trimestre anterior) | 7 (-1 vs trimestre anterior) | 7 (-2 vs trimestre anterior) | -483K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| Deep Track Capital, LP | $2 562 515 | 444 110 | 16,70% | Acciones |
| Alyeska Investment Group, L.P. | $2 377 240 | 412 000 | 15,49% | Acciones |
| Sio Capital Management, LLC | $1 888 157 | 327 237 | 12,30% | Acciones |
| VANGUARD GROUP INC | $1 867 682 | 200 395 | 12,17% | Acciones |
| MARSHALL WACE, LLP | $1 422 761 | 246 579 | 9,27% | Acciones |
| Woodline Partners LP | $1 023 379 | 177 362 | 6,67% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $1 012 883 | 175 543 | 6,60% | Acciones |
| BAKER BROS. ADVISORS LP | $479 227 | 83 055 | 3,12% | Acciones |
| HHLR ADVISORS, LTD. | $439 945 | 76 247 | 2,87% | Acciones |
| D. E. Shaw & Co., Inc. | $383 491 | 66 463 | 2,50% | Acciones |
| UBS Group AG | $346 119 | 59 986 | 2,26% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $272 319 | 47 173 | 1,77% | Acciones |
| JANE STREET GROUP, LLC | $186 959 | 32 402 | 1,22% | Acciones |
| BlackRock, Inc. | $174 785 | 30 292 | 1,14% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $165 091 | 28 612 | 1,08% | Acciones |
| AlphaQuest LLC | $129 324 | 13 876 | 0,84% | Acciones |
| DIMENSIONAL FUND ADVISORS LP | $121 424 | 21 044 | 0,79% | Acciones |
| TWO SIGMA ADVISERS, LP | $121 160 | 13 000 | 0,79% | Acciones |
| Verition Fund Management LLC | $108 978 | 18 887 | 0,71% | Acciones |
| Trexquant Investment LP | $71 196 | 12 339 | 0,46% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $62 316 | 10 800 | 0,41% | Acciones |
| Rockefeller Capital Management L.P. | $57 700 | 10 000 | 0,38% | Acciones |
| Federation des caisses Desjardins du Quebec | $26 831 | 4 650 | 0,17% | Acciones |
| Golden State Wealth Management, LLC | $15 429 | 2 674 | 0,10% | Acciones |
| ROYAL BANK OF CANADA | $12 000 | 2 125 | 0,08% | Acciones |
| CITIGROUP INC | $10 432 | 1 808 | 0,07% | Acciones |
| Tower Research Capital LLC (TRC) | $2 071 | 359 | 0,01% | Acciones |
| JPMORGAN CHASE & CO | $1 868 | 344 | 0,01% | Acciones |
| MORGAN STANLEY | $1 177 | 204 | 0,01% | Acciones |
| SBI Securities Co., Ltd. | $727 | 126 | 0,00% | Acciones |
| WELLS FARGO & COMPANY/MN | $577 | 100 | 0,00% | Acciones |
| FMR LLC | $58 | 10 | 0,00% | Acciones |
| ELEVATION WEALTH PARTNERS, LLC | $24 | 4 | 0,00% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $17 | 3 | 0,00% | Acciones |
Activistas y propietarios del %+ 5 4 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Lawrence M. Blatt ×2 presentaciones | 24 de junio de 2026 | 5,60% | Presentación inicial | Inversión pasiva | SEC |
| Versant Venture Capital VI, L.P., Versant Ventures VI GP, L.P., Versant Ventures VI GP-GP, LLC, Versant Vantage I, L.P., Versant Vantage I GP, L.P., Versant Vantage I GP-GP, LLC ×4 presentaciones | 8 de febrero de 2024 | · | Presentación inicial | · | SEC |
| Lawrence M. Blatt, Ph.D. | 6 de noviembre de 2023 | · | Presentación inicial | Inversión pasiva | SEC |
| Novo Holdings A/S ×3 presentaciones | 31 de enero de 2022 | · | Presentación inicial | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 18 insiders · 8 directivos · 10 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Lawrence M. Blatt, Ph.D. | President and CEO | 9 de marzo de 2026 A | 1 847 575 | 0 | 0 | $0 |
| Lesley Ann Calhoun | Chief Operating Officer and Chief Financial Officer | 9 de marzo de 2026 A | · | 0 | 0 | $0 |
| Leonid Beigelman | President | 15 de marzo de 2023 A | 18 355 | 0 | 0 | $0 |
| Nikhil Aneja | Principal Accounting Officer | 9 de marzo de 2026 A | · | 0 | 0 | $0 |
| Julian A. Symons | Executive Vice President, Chief Scientific Officer | 9 de marzo de 2026 A | 394 064 | 0 | 0 | $0 |
| Hardean Achneck | Chief Medical Officer | 8 de octubre de 2024 A | · | 0 | 0 | $0 |
| Matthew W. Mcclure | Chief Medical Officer | 1 de marzo de 2024 A | · | 0 | 0 | $0 |
| Lucinda Y. Quan | Executive Vice President, Chief Business Officer and General Counsel | 8 de septiembre de 2023 A | 9 258 | 0 | 0 | $0 |
| Margarita Chavez | Consejero | 25 de junio de 2026 A | · | 0 | 0 | $0 |
| Peter Hirth | Consejero | 25 de junio de 2026 A | · | 0 | 0 | $0 |
| Carole Nuechterlein | Consejero | 25 de junio de 2026 A | 11 025 941 | 0 | 0 | $0 |
| Bridget A Martell | Consejero | 25 de junio de 2026 A | · | 0 | 0 | $0 |
| Heather Preston | Consejero | 25 de junio de 2026 A | · | 0 | 0 | $0 |
| James Paul Scopa | Consejero | 25 de junio de 2026 A | 183 083 | 0 | 0 | $0 |
| Jack Nielsen | Consejero | 28 de febrero de 2024 A | · | 0 | 0 | $0 |
| Thomas Woiwode | Consejero | 23 de junio de 2022 A | 4 452 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | Propietario del 10% | 20 de octubre de 2020 C | 1 906 191 | 0 | 0 | $0 |
| Novo Holdings A/S | Propietario del 10% | 20 de octubre de 2020 C | 2 614 563 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 6 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IWC · iShares Trust | 0,01% | 16 320 SH | 11 de septiembre de 2026 | Diario |
| DFSU · Dimensional ETF Trust | 0,00% | 1 149 NS | 31 de julio de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 2 810 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 46 773 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 128 770 SH | 19 de agosto de 2026 | Diario |
| DFAC · Dimensional ETF Trust | 0,00% | 1 855 NS | 31 de julio de 2026 | N-PORT |
ALGS Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 14 analistas
COMPRA
Objetivo mediano
$40.50
+631,0%
3 21,4%
Compra fuerte
10 71,4%
Compra
1 7,1%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
8 analistas · 2026-10-02Objetivo medio $52.38 +845,4%
← Por Debajo de Todos los Objetivos
Precio Actual $5.54
Mín$20.00
Media$52.38
Máx$175.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 6, 2026